To investigate this, we developed a murine lung cancer model (Supplemental Figure 8A) and evaluated whether dysbiosis reduced the CXCL9 level in BALF and the antitumor effect of anti–PD-1 antibodies in vivo. The gene discussed is CXCL9; the disease is lung cancer.